Marva repurposes bacterial extracellular vesicles—tiny particles bacteria use to communicate and transport cargo—to deliver targeted antimicrobial treatments directly to resistant microbes. By using biology's own delivery vehicles, Marva is building a more precise platform that bypasses the broad chemical approaches accelerating resistance across healthcare, agriculture, and industry.